Delivery Order SPE2DE21D7020-SPE2D626F7907
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,580.66 by the Defense Health Agency's Medical Supply Chain division on October 24, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, is scheduled for completion by October 31, 2025. This delivery order is issued without a small business set-aside, allowing Boston Scientific to compete on an...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $4,235.60 by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on October 29, 2025, with an ultimate completion date of November 5, 2025, is characterized by fixed-price pricing with economic price adjustment terms. This award represents a task order issued against Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,688.80 by the Defense Health Agency's Medical Supply Chain division on September 29, 2023, with an ultimate completion date of October 6, 2023. This fixed-price delivery order with economic price adjustment was issued against an established Blanket Purchase Agreement (BPA) and carries no small business set-aside designation. The contract represents Boston Scientific's continued role...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $29,701.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by October 23, 2025, and represents work to be performed at the contractor's facility in Marlborough, MA. The award was issued without small business set-aside provisions, allowing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,104.60 under a Blanket Purchase Agreement with the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as 4569783311 NC EMERGE MR 15MM, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 28, 2025. The award was issued without a small business set-aside, allowing...
- The Defense Health Agency's Medical Supply Chain division awarded a $31,842.50 fixed-price delivery order with economic price adjustment to Boston Scientific Corp for medical devices and supplies. The contract, effective June 20, 2025, with an ultimate completion date of June 27, 2025, represents a delivery order against Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health Agency valued at $750,000. Boston Scientific, headquartered in Marlborough, Massachusetts,...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,018.22 by the Defense Health Agency's Medical Supply Chain division. The contract, issued on October 31, 2025, is for V-18, 300CM, 12CM poly tip medical devices and carries a fixed-price structure with economic price adjustment provisions. The delivery order is scheduled for completion by November 7, 2025, with performance occurring at Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp has been awarded a delivery order valued at $4,774.65 by the Defense Health Agency's Medical Supply Chain division for the delivery of next-generation synthetic medical devices. The contract, awarded on October 22, 2025, with an ultimate completion date of October 29, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. Performance will take place at Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,492.00 by the Defense Health Agency's Medical Supply Chain division for the provision of medical devices and related supplies. The contract, issued on October 29, 2025, with an ultimate completion date of November 5, 2025, utilizes a fixed-price contract type with economic price adjustment provisions. This delivery order is issued without a small business set-aside, allowing...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F7907Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $1,295.63 under a Defense Health Agency Medical Supply Chain Blanket Purchase Agreement, with a completion deadline of November 7, 2025. This fixed-price contract with economic price adjustment authority represents delivery order activity against Boston Scientific's established single-award BPA with the Defense Health Agency, valued at $750,000 and effective through March 30, 2030. The contract, which carries no small business set-aside designation, supports the Medical Supply Chain's procurement of specialized radiation treatment devices and related oncology equipment for defense and veterans healthcare facilities. Boston Scientific, headquartered in Marlborough, Massachusetts, serves as the sole supplier under this radiation treatment device vehicle. As a leading global medical technology company, Boston Scientific provides critical medical devices and solutions across multiple therapeutic areas to federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency. The company's federal contract portfolio encompasses a comprehensive range of advanced medical technologies, including cardiac devices, neuromodulation systems, interventional devices, and radiation treatment modalities such as yttrium-90 glass microspheres and related radiopharmaceuticals. This delivery order represents continued execution of Boston Scientific's established supply relationship with the Defense Health Agency to support ongoing radiation oncology requirements across military and veterans healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/31/25 |